Daniel Salvatore Barron

Daniel Salvatore Barron

Auto-generated profile, based on publicly available information

Daniel Salvatore Barron

Yale University Department of Psychiatry

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Nature
Verified
Journal Article
Open access
PDF file
AGAbigail S. Greene
Abigail S. Greene
XSXilin Shen
Xilin Shen
SNStephanie Noble
Stephanie Noble
CHCorey Horien
Corey Horien
CHC. Alice Hahn
C. Alice Hahn
RCR. Todd Constable
R. Todd Constable
Individual differences in brain functional organization track a range of traits, symptoms and behaviours1–12. So far, work modelling linear brain–phenotype relationships has assumed that a single such relationship generalizes across all individuals, but models do not work equally well in all participants13,14. A better understanding of in whom models fail and why is crucial to revealing robust, useful and unbiased brain–phenotype relationships. To this end, here we related brain activity to phenotype using predictive models—trained and tested on independent data to ensure generalizability15—and examined model failure. We applied this data-driven approach to a range of neurocognitive measures in a new, clinically and demographically heterogeneous dataset, with the results replicated in two independent, publicly available datasets16,17. Across all three datasets, we find that models reflect not unitary cognitive constructs, but rather neurocognitive scores intertwined with sociodemographic and clinical covariates; that is, models reflect stereotypical profiles, and fail when applied to individuals who defy them. Model failure is reliable, phenotype specific and generalizable across datasets. Together, these results highlight the pitfalls of a one-size-fits-all modelling approach and the effect of biased phenotypic measures18–20 on the interpretation and utility of resulting brain–phenotype models. We present a framework to address these issues so that such models may reveal the neural circuits that underlie specific phenotypes and ultimately identify individualized neural targets for clinical intervention.

2 May 2018 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
TVThomas J. Vanasse
Thomas J. Vanasse
PFP. Mickle Fox
P. Mickle Fox
DBDaniel S. Barron
Daniel S. Barron
MRMichaela Robertson
Michaela Robertson
SESimon B. Eickhoff
Simon B. Eickhoff
PFPeter T. Fox
Peter T. Fox
The BrainMap database is a community resource that curates peer‐reviewed, coordinate‐based human neuroimaging literature. By pairing the results of neuroimaging studies with their relevant meta‐data, BrainMap facilitates coordinate‐based meta‐analysis (CBMA) of the neuroimaging literature en masse or at the level of experimental paradigm, clinical disease, or anatomic location. Initially dedicated to the functional, task‐activation literature, BrainMap is now expanding to include voxel‐based morphometry (VBM) studies in a separate sector, titled: BrainMap VBM. VBM is a whole‐brain, voxel‐wise method that measures significant structural differences between or within groups which are reported as standardized, peak x–y–z coordinates. Here we describe BrainMap VBM, including the meta‐data structure, current data volume, and automated reverse inference functions (region‐to‐disease profile) of this new community resource. CBMA offers a robust methodology for retaining true‐positive and excluding false‐positive findings across studies in the VBM literature. As with BrainMap's functional database, BrainMap VBM may be synthesized en masse or at the level of clinical disease or anatomic location. As a use‐case scenario for BrainMap VBM, we illustrate a trans‐diagnostic data‐mining procedure wherein we explore the underlying network structure of 2,002 experiments representing over 53,000 subjects through independent components analysis (ICA). To reduce data‐redundancy effects inherent to any database, we demonstrate two data‐filtering approaches that proved helpful to ICA. Finally, we apply hierarchical clustering analysis (HCA) to measure network‐ and disease‐specificity. This procedure distinguished psychiatric from neurological diseases. We invite the neuroscientific community to further exploit BrainMap VBM with other modeling approaches.

6 May 2014 in Epilepsia
Verified
Journal Article
Open access
PDF file
DBDaniel S. Barron
Daniel S. Barron
NTNitin Tandon
Nitin Tandon
JLJack L. Lancaster
Jack L. Lancaster
PFPeter T. Fox
Peter T. Fox
Summary: The thalamus has been implicated in various stages of medial temporal lobe epilepsy (MTLE) seizure evolution. The relative density and functional significance (in epileptogenesis) of thalamic projections to MTL subregions, however, remains to be determined. This study used structural and diffusion magnetic resonance imaging (MRI) to evaluate thalamic connection density with distinct MTL subregions in terms of location and volume. Nineteen MTLE patients with unilateral hippocampal sclerosis (HS; 12 right; 10 female) were compared to 19 age‐matched controls. Five regions of interest (ROIs) per hemisphere were created in native space: thalamus, amygdala, entorhinal cortex, hippocampus, and parahippocampus. Separate probabilistic tractography analyses were performed between the thalamus and each ipsilateral MTL subregion (four per hemisphere). Individual connectivity profiles and regional volumes were assessed. The medial pulvinar consistently showed the highest connection density with the hippocampus in healthy controls and in MTLE patients. Decreased thalamic connected volume was observed for thalamohippocampal pathways in patients with MTLE, and indicates pathway‐specific deafferentation. Regional hippocampal and thalamic atrophy was also observed, indicating gray and white matter loss in the thalamohippocampal pathway. Consistent localization of dense medial pulvinar (PuM) connectivity with the hippocampus suggests chronic PuM stimulation could modulate the MTLE seizure network. Decreased thalamic connected volume is a promising biomarker for epileptogenesis that merits longitudinal validation.A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.

21 December 2020 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
DBDaniel S Barron
Daniel S Barron
SGSiyuan Gao
Siyuan Gao
JDJavid Dadashkarimi
Javid Dadashkarimi
AGAbigail S Greene
Abigail S Greene
MSMarisa N Spann
Marisa N Spann
DSDustin Scheinost
Dustin Scheinost
Memory deficits are observed in a range of psychiatric disorders, but it is unclear whether memory deficits arise from a shared brain correlate across disorders or from various dysfunctions unique to each disorder. Connectome-based predictive modeling is a computational method that captures individual differences in functional connectomes associated with behavioral phenotypes such as memory. We used publicly available task-based functional MRI data from patients with schizophrenia (n = 33), bipolar disorder (n = 34), attention deficit hyper-activity disorder (n = 32), and healthy controls (n = 73) to model the macroscale brain networks associated with working, short- and long-term memory. First, we use 10-fold and leave-group-out analyses to demonstrate that the same macroscale brain networks subserve memory across diagnostic groups and that individual differences in memory performance are related to individual differences within networks distributed throughout the brain, including the subcortex, default mode network, limbic network, and cerebellum. Next, we show that diagnostic groups are associated with significant differences in whole-brain functional connectivity that are distinct from the predictive models of memory. Finally, we show that models trained on the transdiagnostic sample generalize to novel, healthy participants (n = 515) from the Human Connectome Project. These results suggest that despite significant differences in whole-brain patterns of functional connectivity between diagnostic groups, the core macroscale brain networks that subserve memory are shared.

1 January 2015 in NeuroImage: Clinical
Verified
Journal Article
Open access
DBDaniel S. Barron
Daniel S. Barron
PFPeter T. Fox
Peter T. Fox
HPHeath Pardoe
Heath Pardoe
JLJack Lancaster
Jack Lancaster
LPLarry R. Price
Larry R. Price
TTThomas Thesen
Thomas Thesen
Noninvasive markers of brain function could yield biomarkers in many neurological disorders. Disease models constrained by coordinate-based meta-analysis are likely to increase this yield. Here, we evaluate a thalamic model of temporal lobe epilepsy that we proposed in a coordinate-based meta-analysis and extended in a diffusion tractography study of an independent patient population. Specifically, we evaluated whether thalamic functional connectivity (resting-state fMRI-BOLD) with temporal lobe areas can predict seizure onset laterality, as established with intracranial EEG. Twenty-four lesional and non-lesional temporal lobe epilepsy patients were studied. No significant differences in functional connection strength in patient and control groups were observed with Mann-Whitney Tests (corrected for multiple comparisons). Notwithstanding the lack of group differences, individual patient difference scores (from control mean connection strength) successfully predicted seizure onset zone as shown in ROC curves: discriminant analysis (two-dimensional) predicted seizure onset zone with 85% sensitivity and 91% specificity; logistic regression (four-dimensional) achieved 86% sensitivity and 100% specificity. The strongest markers in both analyses were left thalamo-hippocampal and right thalamo-entorhinal cortex functional connection strength. Thus, this study shows that thalamic functional connections are sensitive and specific markers of seizure onset laterality in individual temporal lobe epilepsy patients. This study also advances an overall strategy for the programmatic development of neuroimaging biomarkers in clinical and genetic populations: a disease model informed by coordinate-based meta-analysis was used to anatomically constrain individual patient analyses.

9 September 2021 in Frontiers in Psychiatry
Verified
Journal Article
Open access
DBDaniel S. Barron
Daniel S. Barron
JBJustin T. Baker
Justin T. Baker
KBKristin S. Budde
Kristin S. Budde
DBDanilo Bzdok
Danilo Bzdok
SESimon B. Eickhoff
Simon B. Eickhoff
JKJohn H. Krystal
John H. Krystal
Why is psychiatry unable to define clinically useful biomarkers? We explore this question from the vantage of data and decision science and consider biomarkers as a form of phenotypic data that resolves a well-defined clinical decision. We introduce a framework that systematizes different forms of phenotypic data and further introduce the concept of decision model to describe the strategies a clinician uses to seek out, combine, and act on clinical data. Though many medical specialties rely on quantitative clinical data and operationalized decision models, we observe that, in psychiatry, clinical data are gathered and used in idiosyncratic decision models that exist solely in the clinician's mind and therefore are outside empirical evaluation. This, we argue, is a fundamental reason why psychiatry is unable to define clinically useful biomarkers: because psychiatry does not currently quantify clinical data, decision models cannot be operationalized and, in the absence of an operationalized decision model, it is impossible to define how a biomarker might be of use. Here, psychiatry might benefit from digital technologies that have recently emerged specifically to quantify clinically relevant facets of human behavior. We propose that digital tools might help psychiatry in two ways: first, by quantifying data already present in the standard clinical interaction and by allowing decision models to be operationalized and evaluated; second, by testing whether new forms of data might have value within an operationalized decision model. We reference successes from other medical specialties to illustrate how quantitative data and operationalized decision models improve patient care.